[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"gastritis-chronic\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:gastritis-chronic":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,47],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100652145","the-prevalence-and-the-pathophysiological-role-of-non-helicobacter-pylori-helicobacter-spp-in-well-defined-gastric-diseases-and-pre--malignancies-100652145",false,"NCT07770126","The Prevalence and the Pathophysiological Role of Non-Helicobacter Pylori Helicobacter Spp. in Well-defined Gastric Diseases and (Pre-) Malignancies","HELIS","Inclusion Criteria:\n\n* part of the study population\n\nExclusion Criteria:\n\n* Patients with a history of H. pylori infection diagnosed by serology, on gastric biopsy, by breath test or on antigen test in stool samples.\n* Pregnancy.\n* Underage patients (\\\u003C 18 years).",true,"ALL","18 Years",{"count":20,"type":21},150,"ESTIMATED","OBSERVATIONAL","The goal of this clinical trial is to discover the prevalence of NHPH bacteria (Non-Helicobacter pylori Helicobacter species) in patients with one of the following conditions:\n\n1. Functional dyspepsia following the Rome IV criteria\n2. Active chronic gastritis, non-H. pylori induced atrophic gastritis, intestinal metaplasia and non-H.pylori gastric dysplasia\n3. Gastric cancer, including siewert type 2 and 3 esophagastric junction cancers In addition, patients undergoing bariatric surgery are included as a control group. This study will be conducted using a prospective analysis in the three targeted study populations. Biopsy specimens routinely taken during the medical procedure or via the resected material in patients belonging to the target groups will be used.\n\nExclusion criteria:\n\n* Patients with a history of H. pylori infection diagnosed by serology, on gastric biopsy, by breath test or on antigen test in stool samples.\n* Pregnancy.\n* Underage patients (\\\u003C 18 years).",[25,26,27,28,29,30,31,32,33],"Functional Dyspepsia","Gastritis","Gastritis Chronic","Gastric Cancer (GC)","Atrophic Gastritis","Intestinal Metaplasia of Gastric Mucosa","Dysplasia Stomach","Helicobacter Infection","NHPH Prevalence","RECRUITING","2026-08-12",{"date":37,"type":38},"2026-08-18","ACTUAL",{"date":40,"type":38},"2025-02-24",{"date":42,"type":21},"2028-03",{"name":44,"class":45},"Universiteit Antwerpen","OTHER",3,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":57,"conditions":58,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":71},"100634666","association-between-microplastic-exposure-and-the-pathological-progression-of-gastric-carcinogenesis-100634666","NCT07542652","Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis","Association of Microplastic Exposure With Pathological Stages of Gastric Mucosal Carcinogenesis: A Cross-Sectional Study","Inclusion Criteria:\n\n* Aged between 18 and 75 years old, gender is not restricted\n* Having a clear diagnosis result within the recent three months and being diagnosed with chronic non - atrophic gastritis, precancerous lesions of gastric cancer, or gastric cancer for the first time\n* Have clear Helicobacter pylori (Hp) test results\n* Be in normal mental state and able to independently complete the questionnaire survey\n\nExclusion Criteria:\n\n* Patients with a history of malignant tumors in other parts\n* Patients who have previously undergone upper gastrointestinal surgery, chemotherapy, or radiotherapy\n* Patients with severe diseases of major organs such as the heart, lungs liver, and kidneys\n* Patients who are currently receiving psychological intervention or taking psychiatric drugs\n* Pregnant or lactating women\n* Patients with severe missing clinical data or questionnaire information\n* Refusing to sign the informed consent form","75 Years",{"count":56,"type":21},450,"The objective of this clinical trial is to explore the correlation between the level of microplastic exposure and the risk of gastric mucosal carcinogenesis, and to evaluate the strength of its effect as an independent risk factor. The main questions it aims to answer include: Does the level of microplastic exposure increase the risk of gastric mucosal carcinogenesis? Can the correlation between the level of microplastic exposure and gastric mucosal carcinogenesis, as well as the sources of high - risk microplastic exposure, be explored through a questionnaire on external microplastic exposure? Researchers will complete a design structured questionnaire and ask participants to fill it out carefully and truthfully to determine whether the level of microplastic exposure increases the risk of gastric mucosal carcinogenesis.",[59,27,60,61],"Gastric Carcinoma","Intestinal Metaplasia","Gastric Precancerous Lesions","2026-04-25",{"date":64,"type":38},"2026-04-30",{"date":66,"type":38},"2026-03-31",{"date":68,"type":21},"2026-12-31",{"name":70,"class":45},"Yongquan Shi",1]